Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
Pakistan
· Delayed Price · Currency is PKR 1,058.94
-3.12 (-0.29%)
At close: Apr 23, 2025
PSX:ABOT Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 68,177 | 55,475 | 49,258 | 42,570 | 35,283 | Upgrade
|
| Revenue Growth (YoY) | 22.90% | 12.62% | 15.71% | 20.65% | 17.00% | Upgrade
|
| Cost of Revenue | 48,283 | 43,715 | 34,821 | 26,554 | 23,499 | Upgrade
|
| Gross Profit | 19,894 | 11,760 | 14,436 | 16,015 | 11,784 | Upgrade
|
| Selling, General & Admin | 10,362 | 8,989 | 7,835 | 7,232 | 5,516 | Upgrade
|
| Other Operating Expenses | 862.48 | 303.19 | 590.58 | 777.55 | 602.55 | Upgrade
|
| Operating Expenses | 11,225 | 9,292 | 8,425 | 8,009 | 6,119 | Upgrade
|
| Operating Income | 8,669 | 2,468 | 6,011 | 8,006 | 5,666 | Upgrade
|
| Interest Expense | -11.74 | -22.18 | -25.41 | -54.48 | -70.39 | Upgrade
|
| Interest & Investment Income | 621.67 | 893.59 | 995.1 | 571.13 | 344.36 | Upgrade
|
| Currency Exchange Gain (Loss) | -16.2 | -1,341 | -779.79 | -240.34 | -105.83 | Upgrade
|
| Other Non Operating Income (Expenses) | 58.55 | 71.27 | 41.08 | 108.9 | 150.21 | Upgrade
|
| EBT Excluding Unusual Items | 9,321 | 2,069 | 6,242 | 8,392 | 5,984 | Upgrade
|
| Gain (Loss) on Sale of Assets | 31.14 | 20.26 | -94.33 | 18.92 | 4.16 | Upgrade
|
| Asset Writedown | -225.04 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | 500.05 | - | - | 255.46 | Upgrade
|
| Pretax Income | 9,128 | 2,590 | 6,148 | 8,410 | 6,244 | Upgrade
|
| Income Tax Expense | 3,893 | 2,328 | 3,143 | 2,443 | 1,708 | Upgrade
|
| Net Income | 5,234 | 261.78 | 3,004 | 5,967 | 4,535 | Upgrade
|
| Net Income to Common | 5,234 | 261.78 | 3,004 | 5,967 | 4,535 | Upgrade
|
| Net Income Growth | 1899.50% | -91.29% | -49.65% | 31.57% | 248.90% | Upgrade
|
| Shares Outstanding (Basic) | 98 | 98 | 98 | 98 | 98 | Upgrade
|
| Shares Outstanding (Diluted) | 98 | 98 | 98 | 98 | 98 | Upgrade
|
| EPS (Basic) | 53.46 | 2.67 | 30.69 | 60.95 | 46.33 | Upgrade
|
| EPS (Diluted) | 53.46 | 2.67 | 30.69 | 60.95 | 46.33 | Upgrade
|
| EPS Growth | 1899.50% | -91.29% | -49.65% | 31.57% | 248.90% | Upgrade
|
| Free Cash Flow | 1,652 | -3,137 | 212.23 | 5,768 | 6,768 | Upgrade
|
| Free Cash Flow Per Share | 16.87 | -32.04 | 2.17 | 58.92 | 69.13 | Upgrade
|
| Dividend Per Share | 10.000 | - | 15.000 | 40.000 | 40.000 | Upgrade
|
| Dividend Growth | - | - | -62.50% | - | 433.33% | Upgrade
|
| Gross Margin | 29.18% | 21.20% | 29.31% | 37.62% | 33.40% | Upgrade
|
| Operating Margin | 12.72% | 4.45% | 12.20% | 18.81% | 16.06% | Upgrade
|
| Profit Margin | 7.68% | 0.47% | 6.10% | 14.02% | 12.85% | Upgrade
|
| Free Cash Flow Margin | 2.42% | -5.65% | 0.43% | 13.55% | 19.18% | Upgrade
|
| EBITDA | 10,366 | 3,966 | 7,368 | 9,119 | 6,649 | Upgrade
|
| EBITDA Margin | 15.20% | 7.15% | 14.96% | 21.42% | 18.84% | Upgrade
|
| D&A For EBITDA | 1,697 | 1,498 | 1,357 | 1,113 | 983.72 | Upgrade
|
| EBIT | 8,669 | 2,468 | 6,011 | 8,006 | 5,666 | Upgrade
|
| EBIT Margin | 12.72% | 4.45% | 12.20% | 18.81% | 16.06% | Upgrade
|
| Effective Tax Rate | 42.65% | 89.89% | 51.13% | 29.05% | 27.36% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.